Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study
Article
Prados, MD, Yung, WKA, Jaeckle, KA et al. (2004). Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study
. NEURO-ONCOLOGY, 6(1), 44-54. 10.1215/S1152851703000292
Prados, MD, Yung, WKA, Jaeckle, KA et al. (2004). Phase 1 trial of irinotecan (CPT-11) in patients with recurrent malignant glioma: A North American Brain Tumor Consortium study
. NEURO-ONCOLOGY, 6(1), 44-54. 10.1215/S1152851703000292